Rukobia (fostemsavir)

pCPA File Number: 22371

Negotiation Status:

Active Negotiation

Indication(s):

For use in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen due to resistance, intolerance or safety considerations

Sponsor/Manufacturer:

ViiV Healthcare

CADTH Project Number:

SR0760

pCPA Engagement Letter Issued:

2024-02-13

Negotiation Process Concluded:

Not Applicable